• Publications
  • Influence
Delayed sleep phase syndrome: a review of its clinical aspects.
The management and outcome of the largest series of patients with delayed sleep phase syndrome thus far reported, which was often associated with major depression and was more resistant to treatment than other sleep disorders, is described. Expand
Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII–R primary insomnia
Both trazodone and zolpidem improved self‐reported sleep latency and duration of non‐depressed, primary insomniacs; zolPidem was somewhat more efficacious at the doses studied. Expand
Sleep debt and depression in female college students
Among female college students, those who report a sleep debt of at least 2 h or significant daytime sleepiness have a higher risk of reporting melancholic symptoms than others, and sleep problems explained 13% of the variance for both the CESD scale and the HAM-D-3 scale. Expand
Self-reported hyperarousal traits among insomnia patients.
Self-report findings suggest that insomnia subjects may be more responsive generally, and all sleep disorder groups had increased total Hyperarousal scores, although these increases were accounted for by different scale items. Expand
Antidepressant "treatment".
Self-reported sleep in postmenopausal women
Self-reports of lower sleep quality were associated with increased WHQ psychological and somatic symptom measures and decreased cognitive test performance more than with differences in objective sleep. Expand
Treatment of delayed sleep phase syndrome.
Bright light treatment potentially corrects the circadian abnormality of DSPS and the safety and efficacy of light treatment have not been conventionally defined, but available information suggests that it is ophthalmologically safe. Expand
Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management.
It is concluded that psychologic and neurophysiologic factors may predispose to life-threatening cardiac arrhythmia in the absence of organic heart disease. Expand
Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia
It is suggested that a single most effective and safe treatment option for people with dementia may not exist, and insufficient evidence exists on which atypical antipsychotic is both safest and most beneficial across several measures. Expand
Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement.
Adding meT treatment may improve complex information processing and an increased chance of overall improvement may be predicted by specific pretreatment measures. Expand